These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16718754)

  • 21. Frontiers in functional dyspepsia.
    Fajardo NR; Cremonini F; Talley NJ
    Curr Gastroenterol Rep; 2005 Aug; 7(4):289-96. PubMed ID: 16042912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Combination of Cholecystokinin and Stress Amplifies an Inhibition of Appetite, Gastric Emptying, and an Increase in c-Fos Expression in Neurons of the Hypothalamus and the Medulla Oblongata.
    Yamaguchi N; Hosomi E; Hori Y; Ro S; Maezawa K; Ochiai M; Nagoshi S; Takayama K; Yakabi K
    Neurochem Res; 2020 Sep; 45(9):2173-2183. PubMed ID: 32661781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cholecystokinin and its antagonists: effects on digestive motility].
    Bruley des Varannes S; Cloarec D; Dubois A; Galmiche JP
    Gastroenterol Clin Biol; 1991; 15(10):744-57. PubMed ID: 1816015
    [No Abstract]   [Full Text] [Related]  

  • 24. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
    Wu CL; Doong ML; Wang PS
    Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA; de Boer SY; Lam WF; Rovati LC; Lamers CB; Masclee AA
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin does not delay gastric emptying of regular meals in healthy humans.
    Niederau C; Mecklenbeck W; Heindges T
    Hepatogastroenterology; 1993 Aug; 40(4):380-3. PubMed ID: 8406310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans.
    Konturek SJ; Kwiecien N; Obtulowicz W; Kopp B; Oleksy J; Rovati L
    Digestion; 1990; 45(1):1-8. PubMed ID: 2340960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin is a regulator of intestinal phase-stimulated PP release.
    Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A
    Regul Pept; 1990 Sep; 30(2):105-11. PubMed ID: 2274676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin.
    Peters JH; Simasko SM; Ritter RC
    Physiol Behav; 2006 Nov; 89(4):477-85. PubMed ID: 16872644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a modified rat model for functional dyspepsia.
    Liang Q; Yan Y; Mao L; Du X; Liang J; Liu J; Wang L; Li H
    Saudi J Gastroenterol; 2018; 24(4):228-235. PubMed ID: 29652029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.
    Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):406-13. PubMed ID: 12690433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of endogenous CCK and CCK1 receptors in colonic motor function.
    Varga G; Bálint A; Burghardt B; D'Amato M
    Br J Pharmacol; 2004 Apr; 141(8):1275-84. PubMed ID: 15100163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional dyspepsia patients have lower mucosal cholecystokinin concentrations in response to duodenal lipid.
    van Boxel OS; ter Linde JJ; Oors J; Otto B; Weusten BL; Feinle-Bisset C; Smout AJ; Siersema PD
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):205-12. PubMed ID: 24252886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current understanding of pathogenesis of functional dyspepsia.
    Miwa H; Watari J; Fukui H; Oshima T; Tomita T; Sakurai J; Kondo T; Matsumoto T
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():53-60. PubMed ID: 21443711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of cholecystokinin and its antagonists on the GI tract. Potent inhibition of gastrointestinal motility by loxiglumide].
    Schmidt WE
    Fortschr Med; 1992 Oct; 110(28):521-2. PubMed ID: 1398411
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity.
    Mönnikes H; Tebbe JJ; Hildebrandt M; Arck P; Osmanoglou E; Rose M; Klapp B; Wiedenmann B; Heymann-Mönnikes I
    Dig Dis; 2001; 19(3):201-11. PubMed ID: 11752838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticholecystokinin activities of loxiglumide.
    Setnikar I; Bani M; Cereda R; Chisté R; Makovec F; Pacini MA; Revel L
    Arzneimittelforschung; 1987 Oct; 37(10):1168-71. PubMed ID: 3435589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia.
    Feinle C; Meier O; Otto B; D'Amato M; Fried M
    Gut; 2001 Mar; 48(3):347-55. PubMed ID: 11171824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.